MMA
CELG

Miracle Mile Advisors’s Celgene Corp CELG Stock Holding History

Miracle Mile Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,467
Closed -$214K – 114
2017
Q3 		$214K Buy
+1,467
New +$200K 0.04% 69
2017
Q2 		– Sell
-1,795
Closed -$223K – 85
2017
Q1 		$223K Sell
1,795
-91
-5% -$10.9K 0.04% 73
2016
Q4 		$218K Sell
1,886
-625
-25% -$69.6K 0.05% 76
2016
Q3 		$262K Buy
+2,511
New +$272K 0.07% 65
2016
Q2 		– Sell
-2,287
Closed -$229K – 74
2016
Q1 		$229K Sell
2,287
-240
-9% -$24.7K 0.08% 49
2015
Q4 		$303K Hold
2,527
– – 0.11% 39
2015
Q3 		$273K Hold
2,527
– – 0.09% 44
2015
Q2 		$292K Buy
2,527
+411
+19% +$47K 0.2% 28
2015
Q1 		$239K Buy
+2,116
New +$253K 0.25% 25

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Miracle Mile Advisors's CELG Position: Q4 2017 in Review

Miracle Mile Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,467 shares — an estimated $214K sold.

Miracle Mile Advisors first reported a position in CELG in Q1 2015 and held it in 9 quarters. The position peaked at $303K in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Miracle Mile Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Miracle Mile Advisors sold 1,467 Celgene Corp shares in Q4 2017, an estimated $214K.
  • Miracle Mile Advisors first reported a position in Celgene Corp in Q1 2015 and held it in 9 quarters.
  • Miracle Mile Advisors's Celgene Corp position peaked at $303K in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Miracle Mile Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.